EFDID: 103275EFD: View Filing

Issuer: Neurodyn Life Sciences Inc. (0001568852) - D/A

Accession: 0001140361-14-044465 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001568852
  • Entity Name:
    Neurodyn Life Sciences Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    BRITISH COLUMBIA, CANADA
  • Year of Inc:
    Over 5 years ago
  • Address:
    439 Helmcken Street
    VANCOUVER, A1 V6B 2E6
  • Persons:
    Related Persons 6
    Kenneth A. Cawkell
    Executive Officer, Director
    Denis G. Kay
    Executive Officer, Director
    Robert L. Cervelli
    Director
    James Mertz
    Director
    Madolyn Mertz
    Director
    Richard Devries
    Director
EDGAR: Offering Information
  • Accession Date:
    12/08/2014
  • First Sale Date:
    12/20/2013
  • Offering Amount:
    $896,380
  • Amount Sold:
    $896,380
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    US$1.00=Cdn$1.0784.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Neurodyn Life Sciences Inc./s/ Kenneth A. CawkellKenneth A. CawkellChief Executive Officer2014-12-08
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Mar. 11, 2015 103275: 0001140361-15-011311 Neurodyn Life Sciences Inc.
Offer Amount: $1,408,880
Amount Sold: $1,408,880
D/A Dec. 08, 2014 103275: 0001140361-14-044465 Neurodyn Life Sciences Inc.
Offer Amount: $896,380
Amount Sold: $896,380
D Sep. 25, 2014 103275: 0001140361-14-036467 Neurodyn Life Sciences Inc.
Offer Amount: $660,948
Amount Sold: $660,948